Norges Bank’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $122M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $44.4M | Sell |
|
|||||
|
2024
Q3 | $40.4M | Sell |
|
|||||
|
2024
Q2 | $61.9M | Buy |
|
|||||
|
2024
Q1 | $58.6M | Buy |
|
|||||
|
2023
Q4 | $35.7M | Buy |
|
|||||
|
2023
Q3 | $8.99M | Buy |
|
|||||
|
2023
Q2 | $5.12M | Sell |
|
|||||
|
2023
Q1 | $80.5M | Sell |
|
|||||
|
2022
Q4 | $112M | Buy |
|
|||||
|
2022
Q3 | $92.8M | Buy |
|
|||||
|
2022
Q2 | $83.3M | Buy |
|
|||||
|
2022
Q1 | $77.9M | Buy |
|
|||||
|
2021
Q4 | $65.4M | Buy |
|
|||||
|
2021
Q3 | $73.3M | Buy |
|
|||||
|
2021
Q2 | $71.4M | Buy |
|
|||||
|
2021
Q1 | $66.7M | Sell |
|
|||||
|
2020
Q4 | $67.8M | Sell |
|
|||||
|
2020
Q3 | $71.1M | Sell |
|
|||||
|
2020
Q2 | $91.8M | Sell |
|
|||||
|
2020
Q1 | $68.4M | Buy |
|
|||||
|
2019
Q4 | $84.5M | Sell |
|
|||||
|
2019
Q3 | $77.2M | Hold |
|
|||||
|
2019
Q2 | $72.3M | Hold |
|
|||||
|
2019
Q1 | $75.5M | Hold |
|
|||||
|
2018
Q4 | $61.2M | Hold |
|
|||||
|
2018
Q3 | $105M | Hold |
|
|||||
|
2018
Q2 | $84.2M | Sell |
|
|||||
|
2018
Q1 | $72.7M | Hold |
|
|||||
|
2017
Q4 | $68M | Hold |
|
|||||
|
2017
Q3 | $53.7M | Hold |
|
|||||
|
2017
Q2 | $40.3M | Buy |
|
|||||
|
2017
Q1 | $34.4M | Sell |
|
|||||
|
2016
Q4 | $34.8M | Hold |
|
|||||
|
2016
Q3 | $43.5M | Hold |
|
|||||
|
2016
Q2 | $40.8M | Buy |
|
|||||
|
2016
Q1 | $28.4M | Sell |
|
|||||
|
2015
Q4 | $42.4M | Buy |
|
|||||
|
2015
Q3 | $28.5M | Buy |
|
|||||
|
2015
Q2 | $22.4M | Buy |
|
|||||
|
2015
Q1 | $6.82M | Buy |
|